Jushi Holdings (JUSHF) Change in Accured Expenses (2021 - 2026)
Jushi Holdings (JUSHF) reported Change in Accured Expenses of $3.7 million for Q1 2026, down 36.27% year-over-year from $5.7 million in Q1 2025, and up 325.42% quarter-over-quarter from -$1.6 million in Q4 2025.
Jushi Holdings (JUSHF) Change in Accured Expenses (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Change in Accured Expenses data on file, last reported at $3.7 million in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at $3.7 million, down 36.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 million (down 112.56% YoY), and the FY2025 annual result was $893000.0, down 90.93% from the prior year.
- Change in Accured Expenses advanced to $3.7 million in Q1 2026 per JUSHF's latest filing, from -$1.6 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $10.8 million in Q4 2022 and troughed at -$10.6 million in Q3 2023.
- A 5-year average of $2.0 million and a median of $3.7 million in 2026 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses surged 437.66% in 2023, then plunged 1238.68% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at $10.8 million in 2022, then slumped by 117.74% to -$1.9 million in 2023, then soared by 128.88% to $553000.0 in 2024, then sank by 393.85% to -$1.6 million in 2025, then surged by 325.42% to $3.7 million in 2026.
- Business Quant data shows JUSHF's Change in Accured Expenses at $3.7 million in Q1 2026, -$1.6 million in Q4 2025, and $5.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | Jushi Holdings | - | - | 29.88 Mn | 3.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.66 Mn |
| Mar 31, 2026 | 3.66 Mn |
| Dec 31, 2025 | -1.63 Mn |
| Dec 31, 2025 | -1.63 Mn |
| Sep 30, 2025 | 5.28 Mn |
| Sep 30, 2025 | 5.28 Mn |
| Jun 30, 2025 | -8.51 Mn |
| Jun 30, 2025 | -8.51 Mn |
| Mar 31, 2025 | 5.75 Mn |
| Mar 31, 2025 | 5.75 Mn |
| Dec 31, 2024 | 553,000.00 |
| Dec 31, 2024 | 553,000.00 |
| Sep 30, 2024 | 3.83 Mn |
| Sep 30, 2024 | 3.83 Mn |
| Jun 30, 2024 | -636,000.00 |
| Jun 30, 2024 | -636,000.00 |
| Mar 31, 2024 | 6.10 Mn |
| Mar 31, 2024 | 6.10 Mn |
| Dec 31, 2023 | -1.92 Mn |
| Dec 31, 2023 | -1.92 Mn |